Karin Coyne, VP, Patient-Centered Research, will be speaking at DIA’s Pharmacovigilance and Risk Management Strategies Conference on January 28 as part of Session 2: Patient Perspectives on the Risks and Benefits of Opioid Therapy. Her presentation is titled Validating a Self-Report Measure of Prescription Opioid Misuse and Abuse (the POMAQ) in Patients with Chronic Noncancer Pain: Pathways to Success.
